{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:40:02Z","timestamp":1793209202554,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.lungcan.2024.107824","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T06:28:56Z","timestamp":1715668136000},"page":"107824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Density of tumor-infiltrating NK and Treg cells is associated with 5\u00a0years progression-free and overall survival in resected lung adenocarcinoma"],"prefix":"10.1016","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8891-8657","authenticated-orcid":false,"given":"M\u00e1rton","family":"Szentkereszty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9304-8473","authenticated-orcid":false,"given":"Andrea","family":"Lad\u00e1nyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"G\u00e1lffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f3zsef","family":"T\u00f3v\u00e1ri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0211-5237","authenticated-orcid":false,"given":"Gy\u00f6rgy","family":"Losonczy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.lungcan.2024.107824_b0005","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/cancers14061400","article-title":"Updated prognostic factors in localized NSCLC","volume":"14","author":"Garinet","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.lungcan.2024.107824_b0010","first-page":"12","article-title":"Serum cytokine levels and other associated factors as possible immunotherapeutic targets and prognostic indicators for lung cancer","volume":"13","author":"Zhao","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lungcan.2024.107824_b0015","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2147\/CMAR.S280252","article-title":"Prognostic factors determining survival of patients operated for non-small cell lung cancer with consideration given to morphological parameters of blood","volume":"13","author":"Lochowski","year":"2021","journal-title":"Cancer Manag. Res."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107824_b0020","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1164\/rccm.201409-1671PP","article-title":"The non-small cell lung cancer immune contexture a major determinant of tumor characteristics and patient outcome","volume":"191","author":"Remark","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.lungcan.2024.107824_b0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/jnci\/dju435","article-title":"Objective measurement and clinical significance of TILs in non-small cell lung cancer","volume":"107","author":"Schalper","year":"2015","journal-title":"JNCI-J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.lungcan.2024.107824_b0030","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.immuni.2019.01.020","article-title":"Human FOXP3+ regulatory T cell heterogeneity and function in autoimmunity and cancer","volume":"50","author":"Wing","year":"2019","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.lungcan.2024.107824_b0035","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1002\/eji.200838813","article-title":"NK cells and Treg cells: A fascinating dance cheek to cheek","volume":"38","author":"Zimmer","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"26","key":"10.1016\/j.lungcan.2024.107824_b0040","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.lungcan.2024.107824_b0045","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.4161\/onci.22009","article-title":"Trial watch Prognostic and predictive value of the immune infiltrate in cancer","volume":"1","author":"Senovilla","year":"2012","journal-title":"OncoImmunology"},{"issue":"12","key":"10.1016\/j.lungcan.2024.107824_b0050","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P","article-title":"The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma","volume":"79","author":"Coca","year":"1997","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.lungcan.2024.107824_b0055","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<577::AID-CNCR13>3.0.CO;2-V","article-title":"Prognostic value of intratumoral natural killer cells in gastric carcinoma","volume":"88","author":"Ishigami","year":"2000","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.lungcan.2024.107824_b0060","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1067\/mtc.2001.113026","article-title":"The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma","volume":"121","author":"Takanami","year":"2001","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"3","key":"10.1016\/j.lungcan.2024.107824_b0065","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2559.2009.03379.x","article-title":"The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma","volume":"55","author":"Al-Shibli","year":"2009","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.lungcan.2024.107824_b0070","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/path.5772","article-title":"Infiltration of NK and plasma cells is associated with a distinct immune subset in non-small cell lung cancer","volume":"255","author":"Backman","year":"2021","journal-title":"J. Pathol."},{"key":"10.1016\/j.lungcan.2024.107824_b0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ebiom.2020.102850","article-title":"Immune-infiltration based signature as a novel prognostic biomarker in gastrointestinal stromal tumour","volume":"57","author":"Wei","year":"2020","journal-title":"EBioMedicine"},{"issue":"42","key":"10.1016\/j.lungcan.2024.107824_b0080","doi-asserted-by":"crossref","first-page":"72108","DOI":"10.18632\/oncotarget.19437","article-title":"The integrative clinical impact of tumor-infiltrating T lymphocytes and NK cells in relation to B lymphocyte and plasma cell density in esophageal and gastric adenocarcinoma","volume":"8","author":"Svensson","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.lungcan.2024.107824_b0085","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1073\/pnas.050588297","article-title":"In vivo natural killer cell activities revealed by natural killer cell-deficient mice","volume":"97","author":"Kim","year":"2000","journal-title":"PNAS"},{"issue":"16","key":"10.1016\/j.lungcan.2024.107824_b0090","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1158\/0008-5472.CAN-10-4179","article-title":"Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma","volume":"71","author":"Platonova","year":"2011","journal-title":"Cancer Res."},{"issue":"49","key":"10.1016\/j.lungcan.2024.107824_b0095","doi-asserted-by":"crossref","first-page":"20847","DOI":"10.1073\/pnas.0906481106","article-title":"Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity","volume":"106","author":"Balsamo","year":"2009","journal-title":"PNAS"},{"issue":"6","key":"10.1016\/j.lungcan.2024.107824_b0100","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1158\/0008-5472.CAN-11-2544","article-title":"Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity","volume":"72","author":"Pietra","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.lungcan.2024.107824_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2013.12.005","article-title":"Regulatory T cells in cancer immunotherapy","volume":"27","author":"Nishikawa","year":"2014","journal-title":"Curr. Opin. Immunol."},{"issue":"11","key":"10.1016\/j.lungcan.2024.107824_b0110","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1158\/1078-0432.CCR-11-3216","article-title":"The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: a critical review of the literature","volume":"18","author":"deLeeuw","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107824_b0115","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/bjc.2011.189","article-title":"The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis","volume":"105","author":"Gooden","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.lungcan.2024.107824_b0120","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1200\/JCO.2008.18.7229","article-title":"Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer","volume":"27","author":"Salama","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2024.107824_b0125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1155\/2014\/303929","article-title":"High level of tregs is a positive prognostic marker in patients with HPV- positive oral and oropharyngeal squamous cell carcinomas","volume":"2014","author":"Lukesova","year":"2014","journal-title":"Biomed Res. Int."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107824_b0130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/bjc.2012.524","article-title":"Tumour-infiltrating FOXP3+ lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer","volume":"108","author":"West","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.lungcan.2024.107824_b0135","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/JTO.0b013e3181d60fd7","article-title":"Tumor-infiltrating Foxp3+regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer","volume":"5","author":"Shimizu","year":"2010","journal-title":"J. Thorac. Oncol."},{"issue":"11","key":"10.1016\/j.lungcan.2024.107824_b0140","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1093\/annonc\/mdw319","article-title":"Prognostic value of tumor-infiltrating lymphocytes differs depending on histological type and smoking habit in completely resected non-small-cell lung cancer","volume":"27","author":"Kinoshita","year":"2016","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2024.107824_b0145","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.lungcan.2012.01.004","article-title":"Stromal CD4\/CD25 positive T-cells are a strong and independent prognostic factor in non-small cell lung cancer patients, especially with adenocarcinomas","volume":"76","author":"Kayser","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2024.107824_b0150","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejca.2023.02.012","article-title":"Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer","volume":"185","author":"Backman","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.lungcan.2024.107824_b0155","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fimmu.2021.750046","article-title":"Profiling tumor immune microenvironment of non-small cell lung cancer using multiplex immunofluorescence","volume":"12","author":"Peng","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107824_b0160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1371\/journal.pone.0153954","article-title":"PD-L1 and tumor infiltrating lymphocytes as prognostic markers in resected NSCLC","volume":"11","author":"Ameratunga","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.lungcan.2024.107824_b0165","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejca.2017.08.026","article-title":"Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma","volume":"86","author":"Kinoshita","year":"2017","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.lungcan.2024.107824_b0170","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jtho.2018.12.022","article-title":"Prognostic impact of tumor cell programmed death ligand 1 expression and immune cell infiltration in NSCLC","volume":"14","author":"Edlund","year":"2019","journal-title":"J. Thorac. Oncol."},{"issue":"39","key":"10.1016\/j.lungcan.2024.107824_b0175","doi-asserted-by":"crossref","first-page":"64318","DOI":"10.18632\/oncotarget.11793","article-title":"Expressions of CD8+TILs, PD-L1 and Foxp3+TILs in stage I NSCLC guiding adjuvant chemotherapy decisions","volume":"7","author":"Teng","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.lungcan.2024.107824_b0180","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1053\/j.semtcvs.2017.05.008","article-title":"Programmed death cell ligand 1 (PD-L1) is associated with survival in stage I non-small cell lung cancer","volume":"29","author":"Sepesi","year":"2017","journal-title":"Semin. Thorac. Cardiovasc. Surg."},{"issue":"5","key":"10.1016\/j.lungcan.2024.107824_b0185","doi-asserted-by":"crossref","first-page":"1824-+","DOI":"10.21037\/jtd-19-3414a","article-title":"Tumor infiltrating T cells influence prognosis in stage I-III non-small cell lung cancer","volume":"12","author":"Schulze","year":"2020","journal-title":"J. Thorac. Dis."},{"issue":"6","key":"10.1016\/j.lungcan.2024.107824_b0190","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1183\/13993003.00176-2014","article-title":"Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer","volume":"46","author":"O'Callaghan","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.lungcan.2024.107824_b0195","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/hed.25546","article-title":"Local immune parameters as potential predictive markers in head and neck squamous cell carcinoma patients receiving induction chemotherapy and cetuximab","volume":"41","author":"Lad\u00e1nyi","year":"2019","journal-title":"Head Neck-J. Sci. Spec. Head Neck"},{"issue":"67","key":"10.1016\/j.lungcan.2024.107824_b0200","doi-asserted-by":"crossref","first-page":"7142","DOI":"10.18632\/oncotarget.27392","article-title":"Prognostic value of immune cells in the tumor microenvironment of early-stage lung cancer: a meta-analysis","volume":"10","author":"Tuminello","year":"2019","journal-title":"Oncotarget"},{"issue":"16","key":"10.1016\/j.lungcan.2024.107824_b0205","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.7150\/jca.20172","article-title":"Correlation of cancer stem cell markers and immune cell markers in resected non-small cell lung cancer","volume":"8","author":"Huang","year":"2017","journal-title":"J. Cancer"},{"issue":"2","key":"10.1016\/j.lungcan.2024.107824_b0210","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/jitc-2020-001054","article-title":"Natural killer cells in the human lung tumor microenvironment display immune inhibitory functions","volume":"8","author":"Russick","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.lungcan.2024.107824_b0215","doi-asserted-by":"crossref","unstructured":"L. Schmidt, B. Eskiocak, R. Kohn, C. Dang, N.S. Joshi, M. DuPage, D.Y. Lee, T. Jacks, Enhanced adaptive immune responses in lung adenocarcinoma through natural killer cell stimulation, Proc Natl Acad Sci USA 116(35) (2019) 17460-17469.","DOI":"10.1073\/pnas.1904253116"},{"issue":"1","key":"10.1016\/j.lungcan.2024.107824_b0220","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrc.2015.5","article-title":"NK cells and cancer: you can teach innate cells new tricks","volume":"16","author":"Morvan","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"19","key":"10.1016\/j.lungcan.2024.107824_b0225","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1158\/1078-0432.CCR-11-1347","article-title":"Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression","volume":"17","author":"Parkhurst","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.lungcan.2024.107824_b0230","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1189\/jlb.0707481","article-title":"Impairment of human NK cell cytotoxic activity and cytokine release by cigarette smoke","volume":"83","author":"Mian","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.lungcan.2024.107824_b0235","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.lungcan.2020.09.004","article-title":"KRAS G12D mutation predicts lower TMB and drives immune suppression in lung adenocarcinoma","volume":"149","author":"Gao","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2024.107824_b0240","doi-asserted-by":"crossref","unstructured":"F. Skoulidis, L.A. Byers, L.X. Diao, V.A. Papadimitrakopoulou, P. Tong, J. Izzo, C. Behrens, H. Kadara, E.R. Parra, J.R. Canales, J.J. Zhang, U. Giri, J. Gudikote, M.A. Cortez, C. Yang, Y.H. Fan, M. Peyton, L. Girard, K.R. Coombes, C. Toniatti, T.P. Heffernan, M. Choi, G.M. Frampton, V. Miller, J.N. Weinstein, R.S. Herbst, K.K. Wong, J.H. Zhang, P. Sharma, G.B. Mills, W.K. Hong, J.D. Minna, J.P. Allison, A. Futreal, J. Wang, Wistuba, II, J.V. Heymach, Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities, Cancer Discov. 5(8) (2015) 860-877.","DOI":"10.1158\/2159-8290.CD-14-1236"},{"issue":"5","key":"10.1016\/j.lungcan.2024.107824_b0245","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.immuni.2016.10.021","article-title":"Transcriptional landscape of human tissue lymphocytes unveils uniqueness of tumor-infiltrating T regulatory cells","volume":"45","author":"De Simone","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.lungcan.2024.107824_b0250","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1189\/jlb.0606409","article-title":"Control of NK cell functions by CD4+CD25+ regulatory T cells","volume":"81","author":"Ralainirina","year":"2007","journal-title":"J. Leukoc. Biol."},{"issue":"24","key":"10.1016\/j.lungcan.2024.107824_b0255","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.1158\/1078-0432.CCR-15-2443","article-title":"Image analysis-based assessment of PD-L1 and tumor-associated immune cells density supports distinct intratumoral microenvironment groups in non-small cell lung carcinoma patients","volume":"22","author":"Parra","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.lungcan.2024.107824_b0260","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00262-008-0583-5","article-title":"Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer","volume":"58","author":"Leffers","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"issue":"7","key":"10.1016\/j.lungcan.2024.107824_b0265","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1371\/journal.pone.0006412","article-title":"Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors","volume":"4","author":"Milne","year":"2009","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.lungcan.2024.107824_b0270","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/ni.2683","article-title":"Regulatory T cells in nonlymphoid tissues","volume":"14","author":"Burzyn","year":"2013","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107824_b0275","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41598-020-76130-1","article-title":"Regulatory (FoxP3+) T cells and TGF-\u03b2 predict the response to anti-PD-1 immunotherapy in patients with non-small cell lung cancer","volume":"10","author":"Koh","year":"2020","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.lungcan.2024.107824_b0280","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1002\/eji.201141532","article-title":"Human tumor-induced and naturally occurring Treg cells differentially affect NK cells activated by either IL-2 or target cells","volume":"41","author":"Bergmann","year":"2011","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.lungcan.2024.107824_b0285","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.4049\/jimmunol.176.3.1582","article-title":"CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer","volume":"176","author":"Smyth","year":"2006","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107824_b0290","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1158\/1078-0432.CCR-04-1869","article-title":"Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells","volume":"11","author":"Alvaro","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.lungcan.2024.107824_b0295","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1182\/blood-2006-04-018218","article-title":"High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma","volume":"108","author":"Carreras","year":"2006","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.lungcan.2024.107824_b0300","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.it.2009.01.006","article-title":"NK cell education: not an on-off switch but a tunable rheostat","volume":"30","author":"Brodin","year":"2009","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107824_b0305","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/imr.12175","article-title":"Lineage stability and phenotypic plasticity of Foxp3+ regulatory T cells","volume":"259","author":"Hori","year":"2014","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.lungcan.2024.107824_b0310","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/ncomms15685","article-title":"WASH maintains NKp46+ ILC3 cells by promoting AHR expression","volume":"8","author":"Xia","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lungcan.2024.107824_b0315","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fimmu.2012.00344","article-title":"Mapping of NKp46+ cells in healthy human lymphoid and non-lymphoid tissues","volume":"3","author":"Tomasello","year":"2012","journal-title":"Front. Immunol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500224003581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500224003581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T22:11:42Z","timestamp":1717539102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500224003581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":63,"alternative-id":["S0169500224003581"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2024.107824","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Density of tumor-infiltrating NK and Treg cells is associated with 5\u00a0years progression-free and overall survival in resected lung adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2024.107824","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107824"}}